等待开盘 02-05 09:30:00 美东时间
-0.890
-2.73%
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-09 20:46
Baird analyst Wesley Golladay initiates coverage on Sonida Senior Living (NYSE:SNDA) with a Neutral rating and announces Price Target of $35.
01-09 18:49
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01
Morgan Stanley analyst Ronald Kamdem maintains Sonida Senior Living (NYSE:SNDA) with a Equal-Weight and raises the price target from $26 to $28.
2025-11-19 02:17
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Sonida Senior Living 2025年第三季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **核心财务指标表现强劲:** - 投资组合净营业收入(NOI)同比增长21%,包括2025年新开业或收购的社区 - 调整后EBITDA同比增长超过30%,主要得益于同店NOI增长和一般管理费用(G&A)的有效控制 - 同店每可用房间收入(RevPAR)同比增长4.7% - 护理费用同比增长14%,归因于临床资源和技术投资 - 2024年收购社区的居民费率同比增长4.2% **收购组合表现突出:** - 收购组合NOI环比增长9
2025-11-11 12:09
Sonida Senior Living (NYSE:SNDA) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate of $(0.75) by 108 percent. This is a 59.18 percent decrease over losses of $(0.98) per share
2025-11-10 21:37
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Sonida Senior Living (NYSE:SNDA) will release its quarterly earnings report on ...
2025-11-08 00:03
https://www.wsj.com/real-estate/sonida-in-merger-talks-to-create-one-of-americas-largest-senior-housing-firms-12a569e7
2025-11-05 18:05